Status:

COMPLETED

Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction

Lead Sponsor:

Pine Street Foundation

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

21-120 years

Brief Summary

RATIONALE: Studying samples of exhaled breath from patients with ovarian epithelial cancer, polycystic ovarian syndrome, or endometriosis and from healthy participants in the laboratory may help docto...

Detailed Description

OBJECTIVES: * Identify patterns of exhaled compounds in breath samples from patients with newly diagnosed ovarian epithelial cancer that are significantly and reproducibility different from those of ...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Meets one of the following criteria:
  • Histologically confirmed ovarian epithelial cancer
  • Newly diagnosed disease
  • Diagnosis of polycystic ovarian syndrome or endometriosis
  • Healthy volunteer meeting all of the following criteria:
  • No prior ovarian cancer (including invasive ovarian epithelial cancer, fallopian tube cancer, or primary papillary serous carcinoma of the peritoneum)
  • No prior breast cancer (including ductal carcinoma in situ \[DCIS\])
  • No prior ovarian or breast cancer (including DCIS) in any first- or second-degree relative
  • BRCA1 or BRCA2 mutation negative (if known) OR no first- or second-degree relative with a BRCA1 or BRCA2 mutation (if known)
  • No prior diagnosis of cancer
  • PATIENT CHARACTERISTICS:
  • Lives in California and close to the study sampling centers
  • Reads and writes English, Spanish, or Chinese
  • Non-smoker
  • Willing to provide breath samples
  • No alcohol intake within the past 3 days
  • PRIOR CONCURRENT THERAPY:
  • At least 3 days since prior Cox-2 inhibitors, vitamin E, omega-3 fatty acids, antioxidants, bromelain, coenzyme Q10, curcumin, or vitamin A

Exclusion

    Key Trial Info

    Start Date :

    November 1 2007

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2012

    Estimated Enrollment :

    109 Patients enrolled

    Trial Details

    Trial ID

    NCT00757952

    Start Date

    November 1 2007

    End Date

    December 1 2012

    Last Update

    March 30 2016

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Pine Street Foundation

    San Anselmo, California, United States, 94960-2674

    2

    UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California, United States, 94115

    3

    California Pacific Medical Center - California Campus

    San Francisco, California, United States, 94118

    4

    University of Maine

    Orono, Maine, United States, 04469